Decibel
Decibel Therapeutics is a biotechnology company that develops and commercializes drugs for the treatment of ear, nose and throat diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Decibel Information
Geographic Data
Address: 1325 Boylston Street
City: Boston
State: MA
Zip: 02215
Country: US
Financial Info
Stage:
series d
Raised Last:
$82M
Raised Total:$189M
Social
Metrics
3,771,985Website Global Rank
3,405Website Monthly Traffic
Twitter Followers
Description
Decibel Therapeutics is a biotechnology company that develops and commercializes drugs for the treatment of ear, nose and throat diseases.
Contact Phone:
+16173708701
Contact Email:
Decibel went public on 2/11/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/11/2021
IPO Valuation:
$437M
Ticker Symbol:
DBTX
IPO Price:
$18/share
Amount Raised:
$127M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
